![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | ISO | RGD:1604762 | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of MYLK3 mRNA | CTD | PMID:20404318 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MYLK3 mRNA | CTD | PMID:32741896 | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MYLK3 mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MYLK3 mRNA | CTD | PMID:33387578 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1331868 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of MYLK3 mRNA | CTD | PMID:30951980 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of MYLK3 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases methylation | ISO | RGD:1604762 | 6480464 | Aflatoxin B1 results in increased methylation of MYLK3 intron | CTD | PMID:30157460 | aflatoxin B1 | decreases expression | ISO | RGD:1604762 | 6480464 | Aflatoxin B1 results in decreased expression of MYLK3 mRNA | CTD | PMID:32234424 | Aflatoxin B2 alpha | increases methylation | ISO | RGD:1604762 | 6480464 | aflatoxin B2 results in increased methylation of MYLK3 intron | CTD | PMID:30157460 | amosite asbestos | decreases methylation | ISO | RGD:1604762 | 6480464 | Asbestos, Amosite results in decreased methylation of MYLK3 promoter | CTD | PMID:29626692 | aristolochic acid A | increases expression | ISO | RGD:1604762 | 6480464 | aristolochic acid I results in increased expression of MYLK3 mRNA | CTD | PMID:33212167 | benzalkonium chloride | multiple interactions | ISO | RGD:1331868 | 6480464 | [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of MYLK3 mRNA | CTD | PMID:30171875 | benzo[a]pyrene | increases mutagenesis | ISO | RGD:1604762 | 6480464 | Benzo(a)pyrene results in increased mutagenesis of MYLK3 gene | CTD | PMID:25435355 | benzo[a]pyrene | decreases methylation | ISO | RGD:1604762 | 6480464 | Benzo(a)pyrene results in decreased methylation of MYLK3 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | RGD:1604762 | 6480464 | Benzo(a)pyrene affects the methylation of MYLK3 intron, Benzo(a)pyrene affects the methylation of MYLK3 promoter | CTD | PMID:27901495, PMID:30157460 | benzo[a]pyrene | decreases expression | ISO | RGD:1604762 | 6480464 | Benzo(a)pyrene results in decreased expression of MYLK3 mRNA | CTD | PMID:22316170 | benzo[e]pyrene | increases methylation | ISO | RGD:1604762 | 6480464 | benzo(e)pyrene results in increased methylation of MYLK3 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MYLK3 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | RGD:1331868 | 6480464 | bisphenol A results in increased expression of MYLK3 mRNA | CTD | PMID:32156529 | bisphenol A | decreases methylation | ISO | RGD:1604762 | 6480464 | bisphenol A results in decreased methylation of MYLK3 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | RGD:1331868 | 6480464 | Mifepristone inhibits the reaction [bisphenol A results in decreased expression of MYLK3 mRNA] | CTD | PMID:31566189 | bisphenol A | decreases expression | ISO | RGD:1331868 | 6480464 | bisphenol A results in decreased expression of MYLK3 mRNA | CTD | PMID:31566189 | bisphenol A | increases expression | ISO | RGD:1604762 | 6480464 | bisphenol A results in increased expression of MYLK3 mRNA | CTD | PMID:29275510 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MYLK3 mRNA | CTD | PMID:30816183, PMID:32528016 | bisphenol F | increases expression | ISO | RGD:1331868 | 6480464 | bisphenol F results in increased expression of MYLK3 mRNA | CTD | PMID:30951980 | bromobenzene | decreases expression | EXP | | 6480464 | bromobenzene results in decreased expression of MYLK3 mRNA | CTD | PMID:32479839 | cantharidin | decreases expression | ISO | RGD:1331868 | 6480464 | Cantharidin results in decreased expression of MYLK3 mRNA | CTD | PMID:36907384 | carbon nanotube | decreases expression | ISO | RGD:1604762 | 6480464 | Nanotubes, Carbon results in decreased expression of MYLK3 mRNA | CTD | PMID:25511174 | carbon nanotube | decreases expression | ISO | RGD:1331868 | 6480464 | Nanotubes, Carbon analog results in decreased expression of MYLK3 mRNA | CTD | PMID:25554681 | chlorpyrifos | decreases expression | ISO | RGD:1331868 | 6480464 | Chlorpyrifos results in decreased expression of MYLK3 mRNA | CTD | PMID:37019170 | crocidolite asbestos | decreases methylation | ISO | RGD:1604762 | 6480464 | Asbestos, Crocidolite results in decreased methylation of MYLK3 promoter | CTD | PMID:29626692 | D-mannitol | increases expression | ISO | RGD:1331868 | 6480464 | Mannitol results in increased expression of MYLK3 mRNA | CTD | PMID:25270620 | diazinon | increases methylation | ISO | RGD:1604762 | 6480464 | Diazinon results in increased methylation of MYLK3 gene | CTD | PMID:22964155 | dioxygen | multiple interactions | ISO | RGD:1331868 | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MYLK3 mRNA | CTD | PMID:30529165 | diquat | decreases expression | ISO | RGD:1331868 | 6480464 | Diquat results in decreased expression of MYLK3 mRNA | CTD | PMID:36851058 | dorsomorphin | multiple interactions | ISO | RGD:1604762 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLK3 mRNA | CTD | PMID:27188386 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MYLK3 mRNA | CTD | PMID:33387578 | lidocaine | increases expression | EXP | | 6480464 | Lidocaine results in increased expression of MYLK3 mRNA | CTD | PMID:35283115 | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of MYLK3 mRNA | CTD | PMID:28801915 | mercury dichloride | decreases expression | EXP | | 6480464 | Mercuric Chloride results in decreased expression of MYLK3 mRNA | CTD | PMID:32599119 | methapyrilene | increases methylation | ISO | RGD:1604762 | 6480464 | Methapyrilene results in increased methylation of MYLK3 intron | CTD | PMID:30157460 | microcystin-LR | decreases methylation | ISO | RGD:1604762 | 6480464 | cyanoginosin LR results in decreased methylation of MYLK3 gene | CTD | PMID:29518473 | microcystin-LR | increases expression | ISO | RGD:1604762 | 6480464 | cyanoginosin LR results in increased expression of MYLK3 mRNA | CTD | PMID:29518473 | mifepristone | multiple interactions | ISO | RGD:1331868 | 6480464 | Mifepristone inhibits the reaction [bisphenol A results in decreased expression of MYLK3 mRNA] more ... | CTD | PMID:27264040, PMID:31566189 | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | decreases expression | ISO | RGD:1331868 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MYLK3 mRNA | CTD | PMID:25566086 | ozone | multiple interactions | ISO | RGD:1331868 | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MYLK3 mRNA | CTD | PMID:34911549 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MYLK3 mRNA | CTD | PMID:33387578 | phenylephrine | increases phosphorylation | ISO | RGD:1331868 | 6480464 | Phenylephrine results in increased phosphorylation of MYLK3 protein | CTD | PMID:18202317 | phenylmercury acetate | increases expression | ISO | RGD:1604762 | 6480464 | Phenylmercuric Acetate results in increased expression of MYLK3 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1604762 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLK3 mRNA | CTD | PMID:27188386 | potassium bromate | decreases expression | EXP | | 6480464 | potassium bromate results in decreased expression of MYLK3 mRNA | CTD | PMID:23588252 | progesterone | multiple interactions | ISO | RGD:1331868 | 6480464 | Mifepristone inhibits the reaction [Progesterone results in decreased expression of MYLK3 mRNA] | CTD | PMID:27264040, PMID:31566189 | progesterone | decreases expression | ISO | RGD:1331868 | 6480464 | Progesterone results in decreased expression of MYLK3 mRNA | CTD | PMID:27264040, PMID:31566189 | SB 431542 | multiple interactions | ISO | RGD:1604762 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLK3 mRNA | CTD | PMID:27188386 | serpentine asbestos | decreases methylation | ISO | RGD:1604762 | 6480464 | Asbestos, Serpentine results in decreased methylation of MYLK3 promoter | CTD | PMID:29626692 | sodium arsenite | affects expression | ISO | RGD:1604762 | 6480464 | sodium arsenite affects the expression of MYLK3 mRNA | CTD | PMID:29319823 | sulforaphane | multiple interactions | ISO | RGD:1331868 | 6480464 | [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of MYLK3 mRNA | CTD | PMID:30529165 | sulforaphane | decreases expression | ISO | RGD:1604762 | 6480464 | sulforaphane results in decreased expression of MYLK3 mRNA | CTD | PMID:31838189 | sulforaphane | increases expression | ISO | RGD:1331868 | 6480464 | sulforaphane results in increased expression of MYLK3 mRNA | CTD | PMID:30529165 | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of MYLK3 mRNA | CTD | PMID:32741896 | triclosan | decreases expression | ISO | RGD:1604762 | 6480464 | Triclosan results in decreased expression of MYLK3 mRNA | CTD | PMID:30510588 | triptonide | increases expression | ISO | RGD:1331868 | 6480464 | triptonide results in increased expression of MYLK3 mRNA | CTD | PMID:33045310 | valproic acid | affects expression | ISO | RGD:1331868 | 6480464 | Valproic Acid affects the expression of MYLK3 mRNA | CTD | PMID:17963808 | valproic acid | affects expression | ISO | RGD:1604762 | 6480464 | Valproic Acid affects the expression of MYLK3 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | RGD:1604762 | 6480464 | Valproic Acid results in increased expression of MYLK3 mRNA | CTD | PMID:26272509 | |